Introduction
Leprosy, granulomatous chronic infection leads to neurologic disabilities and physical deformities. Recent researches has shown that Mycobacterium leprae, the causative agent induces lipid droplet formation in infected macrophages, cholesterol accumulates in ML-infected macrophages that can be referred as potential target for drugs [1] . Demyelination of PNS is induced upon attachment of M. laprae to schwann cells where bacteria hides until the infection fully establishes and then spread causing excess chemokines release [1] . WHO-MDT with high effectiveness combines Dapsone, rifampin and clofazimine targets at folate biosynthesis pathway, β-subunit of RNA polymerase and DNA respectively, thus inhibiting replication and transcription in M.leprae [3] .
Methods and Materials
Different Drug's structures (Dapsone, Rifampicin, Clofazimine and Monocycline) are developed in RasMol through online smiles translator, the mode of action of these drugs ( disscussed below) on M. Leprae that causes leprosy were studied from reserach articles and WHO report to make a comparitive study of drugs which are used today. This knowledge could be helpful for the researchers to use them for increasing the effectiveness of treatments or developing new drugs and early diagnosis.
Result and Discussion
Paucibacillary(PB) and Multibacillary(MB) are two different types of leprosy-number of M. leprae in Multibacillary is high whereas in Paucibacillary is small, skin smear test is negative in PB, while it is positive in MB. Monotheraphy of DAPSONE was used to treat patients. But resistant-strain against dapsone became a problem and thus MDT treatment emerged which controlled the spread of drug-resistant strains [3] .
Dapsone, 4,4-diaminodiphenyl sulphonesynthetic sulphone, structurally and functionally related to suphonamide drugs. It targets folate biosynthesis pathway of M. leprae by acting as competitive inhibitor of paminobenzoic acid (PABA) [3] . Rifampicin,3-[[(4-methyl-1-piperazinyl)-imino]-methyl a bactericidal component. Target β-subunit of the RNA polymerase encoded by rpoB [2] . Clofazimine, [3-p-chloroanilino)-10(p-chlorophenyl)-2, 10-dihydro-2-(isopropyl imino) phenazine] -substituted iminophenazine , have anti-mycobacterial and antiinflammatory activity. Highly lipophilic binds preffentially to mycobacterial DNA at base sequences containing guanine [3] . Monocycline, (7-dimethylamino-6-demethyl-6-deoxytetracycline) a bactericidal and its mechanism is thought to be similar to all tetracycline which act by inhibiting protein synthesis. It binds reversibly to 30S ribosomal subunit and blocks the binding of amino acyl RNA transferase to the messenger RNA ribosomal complex [1] .
In this review we have discussed about potential drugs used in Multi Drug Therapy, the most effective treatment for leprosy which have various targets proving leprosy as a curable disease today. 
Conclusions
Leprosy, most dreaded disease is no longer incurable through Multi drug therapy due to its all-round treatment by using combination of effective drugs.
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